Louis Pasquale Discusses Eyenovia’s Trial, Other Causes of Glaucoma, and the Promise of Telemedicine

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 192″]

Louis Pasquale, MD, introduces us to the promising results of Eyenovia’s trial of its Microdrops latanoprost delivery platform. He also talks glaucoma. Is there an unexplored cause? And what promise does telemedicine hold for ophthalmology?